معرفی
Anna-Katharine Brem is a **Lecturer and Group Leader** at the **University Hospital of Old Age Psychiatry and Psychotherapy**, University of Bern, Switzerland. Her research focuses on cognitive and functional improvement in dementia and depression through noninvasive brain stimulation, cognitive training, and remote technologies. She holds a Ph.D. in Neuroscience from the University of Zurich and has held roles at institutions like Harvard Medical School and King’s College London.
Research Interests: Her work integrates clinical psychiatry with neurotechnology, emphasizing translational approaches to neurodegenerative and mental disorders. Key areas include:
- Non-invasive brain stimulation therapies
- Remote monitoring for Alzheimer’s disease
- Cognitive enhancement in aging populations
- Neurophysiological markers of mental health
Collaborations: Partners with institutions such as King’s College London, Harvard Medical School, and the Max Planck Institute of Psychiatry.
Articles Trends: Recent work explores digital health solutions (e.g., wearable devices, AR diagnostics) and neuromodulation for Alzheimer’s and depression, with a focus on clinical translation and accessibility challenges.
Grants & Advising: Leads interdisciplinary teams in clinical trials and technology development. Advises on policy for neurotechnology applications in aging populations.
Labs/Teams: Directs the **Research Group Brem**, focused on bridging clinical neuroscience and innovative therapies.
